Pricing and Market Access Outlook 2018This year’s edition of Pricing and Market Access Outlook, our first as IQVIA, identifies a trend towards models Share XPricing and Market Access Outlook 2018https://pharmaphorum.com/whitepapers/pricing-market-access-outlook-2018/
Keeping ahead of the curveJon Williams, President of Evidera, is well-placed to offer his views on the issues impacting access to therapies. Share XKeeping ahead of the curvehttps://pharmaphorum.com/views-and-analysis/drug-pricing-strategies/